全球軟組織修復市場:各產品(組織固定設備、組織矩陣、細胞療法)、用途、地區(2018年～2023年)

Soft Tissue Repair Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: 2022年01月17日 | 出版商:

Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全貌
簡介
目錄

簡介

全球軟組織修復市場，從預測期間的2018年到2023年預計以約7.4％的年複合成長率發展。

本報告提供全球軟組織修復市場調查，市場概要，各產品、用途、地區的市場規模的變化與預測，市場趨勢，市場成長要素及阻礙因素分析，市場機會，波特的五力分析，競爭情形，主要企業的簡介等全面性資訊。

The soft tissue repair market has been observing a steady growth, with more requirement in increasing number of sports-related injuries. As per the Center for Disease Prevention and Control, participation in organized sports is getting accelerated, and about 30 million children and adolescents participate in youth sports in the United States annually, and more than 2.5 million children and teens are treated for sports-related injuries in the emergency department every year. The most common injuries are sprains and strains. According to the National Athletic Trainers' Association Position Statement: Preventing and Managing Sport-Related Dental and Oral Injuries by Gould TE et al., in 2016, orofacial injuries represented a small percentage of all sport-related injuries, and the financial burden associated with these injuries can exceed USD 15, 000 over adult life. With the growing inclination toward sports in Asia-Pacific region, sports-related injuries have generated a high scope of growth in the soft tissue repair market. According to the research article, 'Football injuries at Asian tournaments' by Yoon et al., there is a higher injury rate at the national team level of soccer in Asia, as compared to Europe. This increasing trend of sports-related injury has been acting as one of the key growth drivers of the soft tissue repair market.

Key Market Trends

Biological Mesh is Expected to provide steady growth over the Forecast Period

The source of biological grafts are human, bovine, and porcine tissues, which have been decellularized to leave a collagen matrix. Biological mesh is used to overcome the complications of synthetic meshes and to provide mechanical support, in order to create highly organized collagen network to establish new vascular access to the hernia site. Biologic grafts represent a major advancement in complex hernia repair when synthetic mesh is inappropriate. The biological mesh is estimated to witness lower CAGR for being more expensive than synthetic mesh. Although biological meshes show great promise in case of hernia repair, however, currently, surgeons prefer synthetic meshes more than biological mesh as connective tissue formed by these materials is only relatively lower. The biological mesh segment is expected to face challenges, due to risk of long-term recurrence and relatively high cost of this mesh.

North America is Estimated to be the Major Region for Majority of Share Over the Forecast Period.

North America is expected to dominate the overall market, throughout the forecast period. In North America region, the United States holds the largest market share and this is due to the due to highly advanced medical care facilities and consistently high healthcare expenditure which would help the growth of the soft tissue repair market in the country.

Competitive Landscape

The Soft Tissue Repair market is competitive and consists of a major players and small players. In terms of market share, these major players currently dominate the market. Some of the major players of the market are Arthrex, Inc., Baxter Healthcare Corporation, Boston Scientific Corporation, Medtronic PLC, Stryker Corporation are among others.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Increasing Incidence of Sports Related Injury
- 4.2.2 Rising Number of Trauma Cases
- 4.2.3 Growing Geriatric Population
4.3 Market Restraints
- 4.3.1 High Cost of Surgical Procedures
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product
- 5.1.1 Tissue Fixation Devices
  - 5.1.1.1 Suture Anchor
  - 5.1.1.2 Sutures
  - 5.1.1.3 Interference Screws
  - 5.1.1.4 Other Devices
- 5.1.2 Tissue Matrix
  - 5.1.2.1 Synthetic Mesh
  - 5.1.2.2 Biologic Mesh
- 5.1.3 Other Products
5.2 By Application
- 5.2.1 Orthopedics
- 5.2.2 Dental Repair
- 5.2.3 Hernia Repair
- 5.2.4 Breast Reconstruction
- 5.2.5 Skin Repair
- 5.2.6 Pelvic and Vaginal Prolapse Repair
- 5.2.7 Others
5.3 Geography
- 5.3.1 North America
  - 5.3.1.1 US
  - 5.3.1.2 Canada
  - 5.3.1.3 Mexico
- 5.3.2 Europe
  - 5.3.2.1 Germany
  - 5.3.2.2 UK
  - 5.3.2.3 France
  - 5.3.2.4 Italy
  - 5.3.2.5 Spain
  - 5.3.2.6 Rest of Europe
- 5.3.3 Asia Pacific
  - 5.3.3.1 China
  - 5.3.3.2 Japan
  - 5.3.3.3 India
  - 5.3.3.4 Australia
  - 5.3.3.5 South Korea
  - 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
  - 5.3.4.1 GCC
  - 5.3.4.2 South Africa
  - 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
  - 5.3.5.1 Brazil
  - 5.3.5.2 Argentina
  - 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
- 6.1.1 Arthrex, Inc.
- 6.1.2 Baxter Healthcare Corporation
- 6.1.3 Boston Scientific Corporation
- 6.1.4 CryoLife, Inc.
- 6.1.5 Integra LifeSciences Corporation
- 6.1.6 Johnson & Johnson
- 6.1.7 Medtronic PLC
- 6.1.8 Becton Dickinson and Company (C.R. Bard, Inc.)
- 6.1.9 Smith & Nephew PLC
- 6.1.10 Stryker Corporation